يعرض 1 - 10 نتائج من 10 نتيجة بحث عن '"P. O. Rumiantsev"', وقت الاستعلام: 0.45s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal

    المصدر: Diagnostic radiology and radiotherapy; Том 14, № 2 (2023); 7-14 ; Лучевая диагностика и терапия; Том 14, № 2 (2023); 7-14 ; 2079-5343

    وصف الملف: application/pdf

    Relation: https://radiag.bmoc-spb.ru/jour/article/view/874/593; Welch G. Cancer Screening — The Good, the Bad, and the Ugly // JAMA Surg. 2022. Jun. 1. Vol. 157, No. 6. Р. 467–468. doi:10.1001/jamasurg.2022.0669.; Marmot M.G., Altman D.G., Cameron D.A. et al. The benefits and harms of breast cancer screening: An independent review // Br. J. Cancer. 2013. Vol. 108, No. 11. Р. 2205–2240. doi:10.1038/bjc.2013.177.; Kuchenbaecker K.B., Hopper J.L., Barnes D.R. et al. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers // JAMA — Journal of the American Medical Association. 2017. Vol. 317, No. 23. Р. 2402–2416. doi:10.1001/jama.2017.7112.; Ilic D., Neuberger M.M., Djulbegovic M., Dahm P. Screening for prostate cancer // Cochrane Database of Systematic Reviews. 2013. Vol. 2013, No. 1. doi:10.1002/14651858.CD004720.pub3.; Gøtzsche P.C., Jørgensen K.J. Screening for breast cancer with mammography // Cochrane Database of Systematic Reviews. 2013. Vol. 2013, No. 6. doi:10.1002/14651858.CD001877.pub5.; Welch H.G., Prorok P.C., O’Malley A.J., Kramer B.S. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness // New England Journal of Medicine. 2016. Vol. 375, No. 15. Р. 1438–1447. doi:10.1056/nejmoa1600249.; McGeoch L., Saunders C.L., Griffin S.J. et al. Risk prediction models for colorectal cancer incorporating common genetic variants: A systematic review // Cancer Epidemiology Biomarkers and Prevention. 2019. Vol. 28, No. 10. Р. 1580–1593. doi:10.1158/1055-9965.EPI-19-0059.; Hugosson J., Roobol M.J., Månsson M. et al. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer (Figure presented) // Eur. Urol. 2019. Vol. 76, No. 1. Р. 43–51. doi:10.1016/j.eururo.2019.02.009.; Bucchi L., Mancini S., Baldacchini F. et al. How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study // Br. J. Cancer. 2022. Vol. 127, No. 3. Р. 541–548. doi:10.1038/s41416-022-01813-7.; Clift A.K., Dodwell D., Lord S. et al. The current status of risk-stratified breast screening // Br. J. Cancer. 2022. Vol. 126, No. 4. Р. 533–550. doi:10.1038/s41416021-01550-3.; Menon U., Gentry-Maharaj A., Burnell M. et al. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial // The Lancet. 2021. Vol. 397, No. 10290. Р. 2182–2193. doi:10.1016/S0140-6736(21)00731-5.; Pashayan N., Morris S., Gilbert F.J., Pharoah P.D.P. Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer A Life-Table Model // JAMA Oncol. 2018. Vol. 4, No. 11. Р. 1504–1510. doi:10.1001/jamaoncol.2018.1901.; Srivastava S., Koay E.J., Borowsky A.D. et al. Cancer overdiagnosis: a biological challenge and clinical dilemma // Nat. Rev. Cancer. 2019. Vol. 19, No. 6. Р. 349– 358. doi:10.1038/s41568-019-0142-8.; Alpert P.F. New Evidence for the Benefit of Prostate-specific Antigen Screening: Data From 400,887 Kaiser Permanente Patients // Urology. 2018. Vol. 118. Р. 119– 126. doi:10.1016/j.urology.2018.02.049.; Bond M., Pavey T., Welch K. et al. Systematic review of the psychological consequences of false-positive screening mammograms // Health Technol Assess (Rockv). 2013. Vol. 17, No. 13. Р. 1–86. doi:10.3310/hta17130.; Sarkeala T., Färkkilä M., Anttila A. et al. Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: Population-based registry study from Finland // BMJ Open. 2021. Vol. 11, No. 2. doi:10.1136/bmjopen-2020-046667.; Hewitson P., Glasziou P., Irwig L. et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult // Cochrane Database of Systematic Reviews. 2007. No. 1. doi:10.1002/14651858.CD001216.pub2.; Adeyemo A., Balaconis M.K., Darnes D.R. et al. Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps // Nat. Med. 2021. Vol. 27, No. 11. Р. 1876–1884. doi:10.1038/s41591-021-01549-6.; Wand H., Lambert S.A., Tamburro C. et al. Improving reporting standards for polygenic scores in risk prediction studies // Nature. 2021. Vol. 591, No. 7849. Р. 211– 219. doi:10.1038/s41586-021-03243-6.; Lenaerts L., Brison N., Maggen C. et al. Comprehensive genome-wide analysis of routine non-invasive test data allows cancer prediction: A single-center retrospective analysis of over 85,000 pregnancies // EClinical. Medicine. 2021. Vol. 35. doi:10.1016/j.eclinm.2021.100856.; Nieuwenburg S.A.V., Mommersteeg M.C., Wolters L.M.M. et al. Accuracy of H. pylori fecal antigen test using fecal immunochemical test (FIT) // Gastric Cancer. 2022. Vol. 25, No. 2. Р. 375–381. doi:10.1007/s10120-021-01264-8.; Newman A.M., Bratman S.V., To J. et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage // Nat. Med. 2014. Vol. 20, No. 5. Р. 548–554. doi:10.1038/nm.3519.; Abou-Elkacem L., Bachawal S.V., Willmann J.K. Ultrasound molecular imaging: Moving toward clinical translation // Eur. J. Radiol. 2015. Vol. 84, No. 9. Р. 1685– 1693. doi:10.1016/j.ejrad.2015.03.016.; Eklund M., Jäderling F., Discacciati A. et al. MRI-Targeted or Standard Biopsy in Prostate Cancer Screening // New England Journal of Medicine. 2021. Vol. 385, No. 10. Р. 908–920. doi:10.1056/nejmoa2100852.; Wang Y., De Leon A.C., Perera R. et al. Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA // Sci. Rep. 2021. Vol. 11, No. 1. doi:10.1038/s41598-021-84072-5.; Falcaro M., Castañon A., Ndlela B. et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study // The Lancet. 2021. Vol. 398, No. 10316. Р. 2084–2092. doi:10.1016/S0140-6736(21)02178-4.; Elemento O., Leslie C., Lundin J., Tourassi G. Artificial intelligence in cancer research, diagnosis and therapy. Nat Rev Cancer. 2021. Vol. 21, No. 12):747–752. doi:10.1038/s41568-021-00399-1.; https://radiag.bmoc-spb.ru/jour/article/view/874

  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10